Johnny John - 08 Feb 2023 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Role
SVP CLINICAL DEV & MED AFFAIRS
Signature
/s/ Gerard Michel, Attorney-in-Fact
Issuer symbol
DCTH
Transactions as of
08 Feb 2023
Net transactions value
$0
Form type
4
Filing time
26 Jan 2024, 16:22:21 UTC
Previous filing
15 Aug 2022
Next filing
21 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCTH Stock Option (Right to Buy) Award $0 +46,800 $0.000000 46,800 08 Feb 2023 Common Stock 46,800 $4.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 8, 2023 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions ofthe Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).